Post Profile






Cancer Moonshot expands data collection to boost access to information

(University of Chicago Medical Center) In response to Vice President Biden's Cancer Moonshot, representatives from government, academic, pharmaceutical and diagnostic companies hope to jump-start the development of an open database for liquid biopsies. The University of Chicago will play a key role, providing data-sharing technology.
read more

share

Related Posts


Medical Students And Residents Have Frequent Interactions With Pharmaceutical Companies, Survey Reveals

Health : Medical News Today

A first-of-its kind national survey of medical students and residents finds that despite recent efforts by medical schools and academic medical centers to restrict access of pharmaceutical sales representatives to medical trainees, ...

NIH’s big cancer database coming soon

Health : The Checkup

Most experts believe that one important element of Vice President Biden's cancer "moonshot" has to be a major database that researchers and clinicians can access to help them develop new therapies or treat patients.Read full article...

Cancer Moonshot program is 'close to gigantic progress', Joe Biden says

Health : The Guardian: Health

Vice-president’s $1bn effort on behalf of cancer research has seen improved information-sharing, report says, but its future is unclear Vice-president Joe Biden’s Cancer Moonshot initiative to speed the development of cancer treatme...

White House To Announce Big Push For Cancer Blood Tests

Industries / Medical : The Medicine Show

The White House, as part of the Cancer Moonshot effort being run by Vice President Joe Biden, is announcing a major push to develop blood tests that can detect and monitor cancer, that aims to unite makers of diagnostic tests, drugs...

VP Biden to report on Cancer Moonshot progress

Health : Reuters: Health

WASHINGTON (Reuters) - U.S. Vice President Joseph Biden will release on Monday a report on the administration's Cancer Moonshot initiative designed to speed the development of new cancer drugs and diagnostics.

Comments


Copyright © 2016 Regator, LLC